Plain-English translation of NCT07343869 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that tracks real-world outcomes in patients undergoing endoscopic submucosal dissection (ESD)—a minimally invasive procedure that removes early esophageal cancers and precancerous growths from the inside of the food pipe. Rather than testing a new medication or treatment, the study follows approximately 750 patients across French medical centers to understand how well this procedure works, what complications may occur, and which patients are at higher risk for the cancer returning.
Esophageal cancer has historically been treated with major surgery, which carries significant risks. Over the past decade, this less invasive endoscopic procedure has become the preferred approach for early-stage disease, but doctors need real-world evidence to better predict which patients will do well, which may need additional treatment, and how to manage potential complications or recurrence.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive the endoscopic procedure as part of your regular cancer care. The study then tracks your health over time through follow-up visits at your hospital center, where doctors will monitor your recovery, test for cancer recurrence, and collect information from your medical records. You will not need to take any experimental medications—instead, researchers will carefully document how you do after the procedure to help improve treatment for future patients.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
France